Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients

被引:1
作者
Sokmen, Dogukan [1 ]
Comez, Yusuf Ilker [2 ]
机构
[1] Androexpertise Clin, Istanbul, Turkiye
[2] Mem Bahcelievler Hosp, Dept Urol, Istanbul, Turkiye
关键词
Chronic prostatitis; chronic pelvic pain syndrome; Li-ESWT; treatment session; erectile function; SYMPTOM INDEX; INTERNATIONAL INDEX; TRIPLE-THERAPY; STIMULATION; ASSOCIATION; VALIDATION; EFFICIENCY;
D O I
10.1080/13685538.2023.2253876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to evaluate the long-term effectiveness of Li-ESWT in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients and to compare the effect of treatment protocol differences on success. Method: Between December 2019 and January 2021, the data of male patients over the age of 18 who applied to the urology outpatient clinic with CP/CPPS symptoms were retrospectively analyzed. International Prostate Symptom Index (IPSS) and International Index of Erectile Function-Erectile Function (IIEF-EF) questionnaires were filled in for the evaluation of erectile function. All patients received treatment with the Medispect Bold Li-ESWT. The treatment responses of the patients who received a total of 6 sessions from one session per week and 12 sessions from two sessions per week were compared. Results: A total of 129 patients were included in the study. Significant improvements were observed in the NIH-CPSI, IPSS, and IIEF-EF scores at the third month follow-ups of the patients after EWST (p < 0.001 for each). Improvements in scores were also found to be significant in NIH-CPSI, IPSS, and IIEF-EF at the 12th month evaluation. When the patients were evaluated according to the number of Li-ESWT sessions they received, the IPSS score average of the patient group who received 12 sessions of Li-ESWT was found to be lower than the patients who received 6 sessions of Li-ESWT (5.67 +/- 2, 30 vs 4.51 +/- 2.21; p = 0.005). There was no significant difference in the IIEF-EF and IPSS scores in the 12th month evaluations of the patients, but the mean NIH-CPSI score was found to be higher in the group that received 12 sessions of LiESWT (p = 0.003). Conclusion: Li-ESWT in the treatment of CP/CPPS patients shows positive improvements in urinary symptoms, erectile function, and quality of life in patients unresponsive to other medical treatments. The increase in the number of sessions does not seem to influence the symptoms of the patients.
引用
收藏
页数:6
相关论文
共 37 条
  • [21] Comparison of the efficiency of combined extracorporeal shock-wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS)
    Pajovic, B.
    Radojevic, N.
    Dimitrovski, A.
    Vukovic, M.
    AGING MALE, 2016, 19 (03) : 202 - 207
  • [22] Exploring the mechanism of Bu Zhong Yi Qi Tang in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) based on network pharmacology and molecular docking
    Zhou, Pengfei
    Xuan, Yang
    Zhu, Zaisheng
    Wu, Han
    Hu, Yang
    Chen, Liangyou
    Zhou, Qianya
    JOURNAL OF MENS HEALTH, 2025, 21 (03) : 77 - 85
  • [23] The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave
    Kong, Xiangbin
    Dong, Zhilong
    Hu, Weiwei
    Mi, Jun
    Xiao, Jie
    Wang, Yiran
    Chen, Wenfang
    Pei, Zixu
    Hao, Zongyao
    Liang, Chaozhao
    Wang, Qi
    Wang, Zhiping
    PROSTATE, 2024, 84 (16) : 1525 - 1536
  • [24] Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results
    Bian, Zichen
    Jin, Chen
    Mo, Fan
    Zhang, Song
    Meng, Jialin
    Zhang, Meng
    Zhang, Li
    Chen, Xianguo
    Hao, Zongyao
    Song, Zhengyao
    Liang, Chaozhao
    ANDROLOGIA, 2022,
  • [25] Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy
    Guu, Shiao-Jin
    Geng, Jiun-Hung
    Chao, I-Ting
    Lin, Hui-Tzu
    Lee, Yung-Chin
    Juan, Yung-Shun
    Liu, Chia-Chu
    Wang, Chii-Jye
    Tsai, Chia-Chun
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (02) : 441 - 452
  • [26] Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
    Ueda, Masakatsu
    Ueda, Tomohiro
    Sengiku, Atsushi
    Kono, Jin
    Saito, Ryoichi
    Negoro, Hiromitsu
    Yoshimura, Naoki
    Ogawa, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 79 - 79
  • [27] Chinese herbal retention enema combined with magnetic vibration magneto-electric therapy: a promising therapeutic strategy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
    Xuan, Yang
    Zhang, Hao
    Shi, Jintao
    Zhu, Weihan
    Fang, Jintao
    Zhang, Qinyu
    Zhou, Qianya
    Chen, Gang
    Duan, Yue
    JOURNAL OF MENS HEALTH, 2025, 21 (03) : 137 - 148
  • [28] Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study
    Kim, Kang Sup
    Choi, Yong Sun
    Bae, Woong Jin
    Cho, Hyuk Jin
    Ha, U-Syn
    Hong, Sung-Hoo
    Lee, Ji Youl
    Ahn, Sun Tae
    Moon, Du Geon
    Kim, Sae Woong
    WORLD JOURNAL OF MENS HEALTH, 2022, 40 (03) : 473 - 480
  • [29] The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial
    Zhang, Kai
    Guo, Run-Qi
    Chen, Shan-Wen
    Chen, Bin
    Xue, Xin-Bo
    Chen, Shan
    Huang, Jian
    Liu, Ming
    Tian, Ye
    Zuo, Li
    Chen, Ming
    Zhou, Li-Qun
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3489 - 3495
  • [30] The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial
    Kai Zhang
    Run-Qi Guo
    Shan-Wen Chen
    Bin Chen
    Xin-Bo Xue
    Shan Chen
    Jian Huang
    Ming Liu
    Ye Tian
    Li Zuo
    Ming Chen
    Li-Qun Zhou
    World Journal of Urology, 2021, 39 : 3489 - 3495